Skip to main content
. 2019 Feb 27;20(6):931–940. doi: 10.1080/15384047.2019.1580414

Figure 4.

Figure 4.

β2m knockdown by siRNA reduces the APLP2 expression level in S2-013 and PANC-1 pancreatic cancer cells, elevates APLP2 expression in MIA PaCa-2 pancreatic cancer cells, and does not significantly change the level of APLP2 in non-transformed hTERT-HPNE pancreatic cells. The indicated cell lines were cultured with β2m siRNA (or scrambled sequence control siRNA) for 72 h and cell lysates were collected and tested by Simple Western for β2m (to verify β2m knockdown by siRNA) and immunoblotted with an antibody for APLP2 or (as the control) Hsc70. The APLP2-specific antibody recognizes both APLP2 and the high molecular weight GAG-modified form of APLP2. The results shown are representative of 5 independent experiments for S2-013, PANC-1, and MIA PaCa-2, and of 2 independent experiments for hTERT-HPNE.